NGS-based BRCA1/2 mutation testing of high-grade serous ovarian cancer tissue: results and conclusions of the first international round robin trial - Endris, V; Stenzinger, A; Pfarr, N; Penzel, R; Mobs, M; Lenze, D (Virch Archiv, 2016)
, et al.